Please assess the completion status of the following clinical trial:

Trial Title: Drug Eluting Balloon for Prevention of Constrictive Remodeling

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* at least one target lesion with a stenosis severity ≥ 50% in one coronary segment with a diameter ≤ 2.5 mm~* age \> 18 years~* weight \> 45 kg~* patient suitable for balloon dilatation and not suitable for elective implantation of a drug eluting stent~* insulin-dependent or non-insulin-dependent diabetes mellitus~* length of lesion ≥ 15 mm~Exclusion Criteria:~* Life expectancy \< 12 months~* In-Stent restenosis~* planned coronary bypass or heart valve OP~* ST elevation myocardial infarction within the last 72 hours~* cardiogenic shock~* renal impairment or liver dysfunction (creatinine \> 2.0 mg/dl, AST/ALT \> 3x of normal value~* incompliance~* pregnant or breastfeeding women or women who like to be pregnant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Paclitaxel coated balloon catheter (Type: ACTIVE_COMPARATOR): Paclitaxel coated balloon catheter IN.PACT Falcon
- uncoated balloon catheter (Type: ACTIVE_COMPARATOR): uncoated balloon catheter sprinter legend

Based on this trial design, predict the completion outcome and termination type (if applicable).